Abstract

To develop technetium and rhenium-labeled imaging agents for estrogen receptor (ER) positive breast tumors, we have synthesized tridentate metal tricarbonyl chelates substituted at the 16α-position of estradiol. Their structures were characterized by IR, 1H NMR, 13C NMR, HRMS or elemental analysis. The rhenium complex 7b showed the highest ER binding affinity (RBA = 25.7) among these compounds, so ligand 6b was selected to be labeled by the precursor [ 99mTc(H 2O) 3(CO) 3] + to yield technetium(I)-99m complex 7b′ with good radiochemical yields. The lipophilicity of corresponding technetium(I)-99m complex 7b′ was appropriately reduced, which might be favorable to target tissue selectivity in vivo. The stability of complex 7b′ is excellent in 1 mM histidine, 1 mM cysteine, PBS and bovine serum within 6 h in vitro.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call